538 related articles for article (PubMed ID: 26511530)
21. Tethered vitreous seeds following intravitreal melphalan for retinoblastoma.
Francis JH; Marr BP; Brodie SE; Gobin YP; Abramson DH
JAMA Ophthalmol; 2014 Aug; 132(8):1024-5. PubMed ID: 25124953
[No Abstract] [Full Text] [Related]
22. Rescue intra-arterial chemotherapy following retinoblastoma recurrence after initial intra-arterial chemotherapy.
Shields CL; Say EA; Pointdujour-Lim R; Cao C; Jabbour PM; Shields JA
J Fr Ophtalmol; 2015 Jun; 38(6):542-9. PubMed ID: 25982423
[TBL] [Abstract][Full Text] [Related]
23. Local and systemic toxicity of intravitreal melphalan for vitreous seeding in retinoblastoma: a preclinical and clinical study.
Francis JH; Schaiquevich P; Buitrago E; Del Sole MJ; Zapata G; Croxatto JO; Marr BP; Brodie SE; Berra A; Chantada GL; Abramson DH
Ophthalmology; 2014 Sep; 121(9):1810-7. PubMed ID: 24819859
[TBL] [Abstract][Full Text] [Related]
24. Intra-Arterial Chemotherapy for Retinoblastoma: A Single-Center Experience.
Akyüz C; Kıratlı H; Şen H; Aydın B; Tarlan B; Varan A
Ophthalmologica; 2015; 234(4):227-32. PubMed ID: 26368674
[TBL] [Abstract][Full Text] [Related]
25. Management and outcome of retinoblastoma with vitreous seeds.
Manjandavida FP; Honavar SG; Reddy VA; Khanna R
Ophthalmology; 2014 Feb; 121(2):517-24. PubMed ID: 24572675
[TBL] [Abstract][Full Text] [Related]
26. Addition of intravitreal carboplatin with melphalan for management of vitreous seeding in retinoblastoma.
Riazi-Esfahani H; Masoomian B; Khodabandeh A; Amini A; Taghizadeh S; Boujabadi L; Sharifkashani S; Shields CL; Ghassemi F
Graefes Arch Clin Exp Ophthalmol; 2023 Apr; 261(4):1167-1175. PubMed ID: 36401651
[TBL] [Abstract][Full Text] [Related]
27. Intravitreal injection of melphalan in the treatment of retinoblastoma with vitreous cavity seeding.
Sun YB; Hui P; Punyara K; Bi MC; Li SH; Teng SY; Song E
Chin Med J (Engl); 2013; 126(8):1587. PubMed ID: 23595400
[No Abstract] [Full Text] [Related]
28. Long-term outcomes of Group D retinoblastoma eyes during the intravitreal melphalan era.
Berry JL; Shah S; Bechtold M; Zolfaghari E; Jubran R; Kim JW
Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28646513
[TBL] [Abstract][Full Text] [Related]
29. Spectral Domain Optical Coherence Tomography Reveals Hidden Fovea Beneath Extensive Vitreous Seeding From Retinoblastoma.
Hasanreisoglu M; Dolz-Marco R; Ferenczy SR; Shields JA; Shields CL
Retina; 2015 Jul; 35(7):1486-7. PubMed ID: 25756924
[No Abstract] [Full Text] [Related]
30. Ocular toxicity of intravitreal melphalan for retinoblastoma in Chinese patients.
Xue K; Ren H; Meng F; Zhang R; Qian J
BMC Ophthalmol; 2019 Feb; 19(1):61. PubMed ID: 30808420
[TBL] [Abstract][Full Text] [Related]
31. Intraocular Pressure Changes Following Intravitreal Melphalan and Topotecan for the Treatment of Retinoblastoma With Vitreous Seeding.
Karl MD; Francis JH; Iyer S; Marr B; Abramson DH
J Pediatr Ophthalmol Strabismus; 2017 May; 54(3):185-190. PubMed ID: 28092395
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and Toxicity of Intravitreous Chemotherapy for Retinoblastoma: Four-Year Experience.
Francis JH; Brodie SE; Marr B; Zabor EC; Mondesire-Crump I; Abramson DH
Ophthalmology; 2017 Apr; 124(4):488-495. PubMed ID: 28089679
[TBL] [Abstract][Full Text] [Related]
33. Intravitreal chemotherapy and laser for newly visible subretinal seeds in retinoblastoma.
Abramson DH; Catalanotti F; Brodie SE; Kellick MG; Francis JH
Ophthalmic Genet; 2018 Jun; 39(3):353-356. PubMed ID: 29513055
[TBL] [Abstract][Full Text] [Related]
34. Intravitreal melphalan therapy for vitreous seeds in retinoblastoma: Implementation and outcomes of a new chemotherapy protocol.
Solana-Altabella A; Valero S; Balaguer J; Escobar-Cava P; Barranco H; López E; Ribes-Artero H; Poveda JL
J Oncol Pharm Pract; 2020 Dec; 26(8):1829-1835. PubMed ID: 32063104
[TBL] [Abstract][Full Text] [Related]
35. Histopathologic observations after intra-arterial chemotherapy for retinoblastoma.
Eagle RC; Shields CL; Bianciotto C; Jabbour P; Shields JA
Arch Ophthalmol; 2011 Nov; 129(11):1416-21. PubMed ID: 21746972
[TBL] [Abstract][Full Text] [Related]
36. Assessment of retinoblastoma RNA reflux after intravitreal injection of melphalan.
Winter U; Nicolas M; Sgroi M; Sampor C; Torbidoni A; Fandiño A; Chantada GL; Munier FL; Schaiquevich P
Br J Ophthalmol; 2018 Mar; 102(3):415-418. PubMed ID: 29089355
[TBL] [Abstract][Full Text] [Related]
37. Selective ophthalmic arterial injection of melphalan for intraocular retinoblastoma: a 4-year review.
Ong SJ; Chao AN; Wong HF; Liou KL; Kao LY
Jpn J Ophthalmol; 2015 Mar; 59(2):109-17. PubMed ID: 25465196
[TBL] [Abstract][Full Text] [Related]
38. Hemorrhage as a sign of treatment failure after intra-arterial chemotherapy in retinoblastoma.
Silva RA; Dubovy SR; Hess D; Stratton R; Murray TG
J AAPOS; 2015 Jun; 19(3):268-70. PubMed ID: 25907829
[TBL] [Abstract][Full Text] [Related]
39. Profiling safety of intravitreal injections for retinoblastoma using an anti-reflux procedure and sterilisation of the needle track.
Munier FL; Soliman S; Moulin AP; Gaillard MC; Balmer A; Beck-Popovic M
Br J Ophthalmol; 2012 Aug; 96(8):1084-7. PubMed ID: 22368262
[TBL] [Abstract][Full Text] [Related]
40. INTRAVITREAL MELPHALAN AS SALVAGE THERAPY FOR REFRACTORY RETINAL AND SUBRETINAL RETINOBLASTOMA.
Francis JH; Marr BP; Brodie SE; Gobin P; Dunkel IJ; Abramson DH
Retin Cases Brief Rep; 2016; 10(4):357-60. PubMed ID: 26630243
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
